Quantcast

Latest Catheter ablation Stories

2010-09-21 15:00:00

Study highlights: -- A medical procedure (catheter ablation) that uses a heat pulse to destroy malfunctioning heart muscle cells successfully treats a common form of irregular heartbeat, known as atrial fibrillation, in patients younger than 45. -- Compared with older patients, those under 45 suffered fewer major complications and were less likely to later require medication to control their irregular heartbeat. -- Researchers' findings suggest that catheter ablation may be an...

2010-09-08 09:23:00

ST. LOUIS, Sept. 8 /PRNewswire-FirstCall/ -- Stereotaxis, Inc. (Nasdaq: STXS) highlighted significant new additions to the body of evidence demonstrating exceptional clinical outcomes achieved with its Niobe® Magnetic Navigation System in ventricular tachycardia (VT) ablation. At the European Cardiology Society Annual Congress in Stockholm last week, the research team led by Dr. Tamas Szili-Torok from the Erasmus Medical Center in Rotterdam presented the first...

2010-07-08 03:59:00

WATERLOO, Belgium, July 8, 2010 /PRNewswire/ -- Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of cardiac arrhythmias, announces that more than 10 patients have now been enrolled in the CLARITY-study ("CLARITY-AF"), comparing the efficacy, safety and efficiency of CARTO(R) 3 System guided radiofrequency ablation using the NAVISTAR(R) THERMOCOOL(R) catheter versus fluoroscopy guided radiofrequency ablation using the Pulmonary Vein Ablation catheter(R) (PVAC(R),...

2010-06-23 07:02:00

RALEIGH, N.C., June 23 /PRNewswire/ -- nContact Surgical, Inc. (nContact) reports with interest today the results of a physician-initiated study of the Convergent Procedure that, for the first time, measured the progress of persistent atrial fibrillation (AF) patients at one-year and six-month intervals. Results of the study, which were presented at the 2010 International Society of Minimally Invasive Cardiac Surgeons (ISMICS) meeting in Berlin, Germany, indicated that after one year 80%...

2010-06-14 06:30:00

CLEVELAND, June 14 /PRNewswire-FirstCall/ -- DATATRAK International, Inc. (OTCQX: DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced that medical technology company Endosense has awarded DATATRAK the first two studies in the EFFICAS study series. The EFFICAS studies are intended to demonstrate that the use of contact force control during cardiac ablation utilizing Endosense's TactiCath®...

2010-05-14 09:11:06

New research presented at National Heart Rhythm Society Sessions shows ablation treatment can eliminate serious risks associated with atrial fibrillation New findings by researchers from the Heart Institute at Intermountain Medical Center in Murray, Utah, reveals treatment of the most common heart rhythm disorder that affects more than two million Americans significantly reduces the risk of stroke, mortality, Alzheimer's disease and other forms of dementia. According to two new studies by the...

2010-05-13 09:36:00

DIAMOND BAR, California, May 13, 2010 /PRNewswire/ -- Biosense Webster, Inc. will underline its leadership position in the electrophysiology market and underscore its commitment to electrophysiologists and their catheter ablation practices at the 2010 Heart Rhythm Meeting. Heart Rhythm is the most important scientific meeting in the field of Electrophysiology and will be held in Denver, CO, USA from May 12th to 15th. This year, Biosense Webster, Inc. will be showcasing its cutting...

2010-05-13 05:00:00

ST. LOUIS, May 13 /PRNewswire-FirstCall/ -- Stereotaxis' (Nasdaq: STXS) safety and efficacy in the treatment of patients with complex arrhythmias such as atrial fibrillation, ventricular tachycardia, and congenital heart defects will be featured prominently in the scientific program of the 31st Annual Heart Rhythm Scientific Sessions in Denver, Colorado. Eight podium presentations and eight posters will underscore the broad clinical leadership that Stereotaxis has achieved in the...

2010-05-04 17:37:00

ST. LOUIS, May 4 /PRNewswire-FirstCall/ -- Stereotaxis, Inc. (Nasdaq: STXS) today updates progress on a global multi-center clinical study on ventricular tachycardia treatment outcomes by using the company's proprietary Niobe® Magnetic Navigation System. Ventricular tachycardia (VT) is a life-threatening arrhythmia because it may lead to ventricular fibrillation, asystole, and sudden death. VT is one of the most challenging arrhythmias facing electrophysiologists due to...

2010-05-04 09:47:00

WALTHAM, Mass., May 4 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, Medtronic could see its heart valve and surgical ablation market shares increase if the company completes its recently announced acquisition of ATS Medical. ATS Medical's device offering is an obvious complement to Medtronic's portfolio; ATS Medical's key product lines overlap with two areas in which Medtronic is seeking to expand its market...


Word of the Day
holluschickie
  • A 'bachelor seal'; a young male seal which is prevented from mating by its herd's older males (mated bulls defending their territory).
This comes from the Russian word for 'bachelors.'
Related